Kidney & Blood Pressure Research (Sep 2022)

Angiotensin II, RAS activation and RAS blockers in COVID-19: unambiguous evidence

  • Lorenzo A. Calò,
  • Lucia Federica Stefanelli,
  • Federico Nalesso

DOI
https://doi.org/10.1159/000526791

Abstract

Read online

N/A